结直肠癌
活性氧
药理学
肠道菌群
肿瘤微环境
癌症研究
化学
天然产物
谷胱甘肽
癌细胞
谷胱甘肽过氧化物酶
益生元
细胞毒性
癌症
代谢物
化疗
生物化学
自噬
生物
免疫原性细胞死亡
医学
细胞
作者
Chengmei Xiao,Yuqi Cao,Kaizhen Wang,Xin Wang,Xiaomin Zhao,Yuhang Miao,Dawei Deng
摘要
The effective absorption of oral chemotherapy drugs in the intestines is of vital importance for enhancing their therapeutic effects. Natural plant-derived compounds, in specific, their diversities in type, structure, and function, might offer opportunities to modulate gut microbiota metabolites for enhancing colorectal cancer therapy. Guided by this thinking, synergistic self-assembly of natural products, namely Xyl-CA/Sin nanoparticles (NPs), was engineered by integrating the prebiotic xylan (Xyl) with chlorogenic acid (CA) and sinomenine (Sin). Xyl protects the formulation during gastric transit and promotes targeted accumulation in colorectal tumors. Upon exposure to the acidic tumor microenvironment (TME), the NPs release CA and Sin, enabling their therapeutic actions. In colorectal cancer (CRC) models, CA triggers tumor cell pyroptosis, while Sin reshapes macrophage polarization and elevates the microbial tryptophan metabolite indole-3-acetic acid (3-IAA). Acting synergistically, 3-IAA and CA suppress glutathione peroxidase 3 (GPx3) and glutathione peroxidase 7 (GPx7), leading to reactive oxygen species (ROS) accumulation and autophagy inhibition. This cascade restrains tumor growth, induces immunogenic cell death (ICD), and stimulates antitumor immunity. Overall, this study presents a microbiota metabolite-driven strategy through the application of natural plant-derived bioactive compounds to potentiate chemotherapy and establishes a concise, multimodal framework for antitumor therapy based on natural products.
科研通智能强力驱动
Strongly Powered by AbleSci AI